Alongside a third-quarter trading update on October 25th, the Chief Executive of GlaxoSmithKline (GSK) admitted that the British group could be interested in acquiring the consumer healthcare arms of US rival Pfizer and Germany’s Merck. (More)
- Given GSK current market cap of £70bn, acquisition of Pfizer’s consumer division (£11bn) and Merck division (£3bn) would be significant acquisitions…
- ....Resulting in the acquired brands being driven hard…
